Filana Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Filana Therapeutics, Inc. (FLNA) reported Increase (Decrease) in Other Noncurrent Assets of $12.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2019-03-29
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2014-12-31 was $0.00.
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2014-09-30 was $0.00.
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2013-12-31 was -$340.00K.
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2011-12-31 was $1.00K.
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2017 was $12.00K.
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2016 was -$12.00K.
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2014 was $12.00K.
- Filana Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2013 was -$352.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2017-12-31 | $12.00K 10-K · filed 2019-03-29 | |||
| 2016-12-31 | -$12.00K 10-K · filed 2018-02-06 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $0.00 derived: sum of 2 quarters · filed 2017-03-07 | $12.00K 10-K · filed 2017-03-07 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $12.00K 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $12.00K 10-Q · filed 2015-07-23 | |||
| 2013-12-31 | -$340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$352.00K 10-K · filed 2016-03-03 | ||
| 2013-09-30 | -$12.00K 10-Q · filed 2014-11-05 | |||
| 2012-06-30 | -$1.00K 10-Q · filed 2013-08-01 | |||
| 2011-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-05 | -$85.00K derived: sum of 2 quarters · filed 2014-02-05 | -$85.00K derived: sum of 3 quarters · filed 2014-02-05 | -$74.00K 10-K · filed 2014-02-05 |
| 2011-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$86.00K derived: sum of 2 quarters · filed 2012-11-09 | -$75.00K 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $11.00K 10-Q · filed 2012-08-02 | ||
| 2011-03-31 | $11.00K 10-Q · filed 2012-05-08 | |||
| 2010-12-31 | -$1.58M 10-K · filed 2013-02-08 | |||
| 2009-12-31 | $440.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |